Quantcast

Latest Clinical cardiac electrophysiology Stories

2011-02-24 07:00:00

SANTA CLARA, Calif., Feb. 24, 2011 /PRNewswire/ -- PR Newswire - NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiovascular diagnostic solutions developer, announced today that the Company has been invited by the Heart Rhythm Society (HRS) to present results of a recent clinical study showing that recurrent atrial fibrillation (AF) was accurately and timely detected in patients who used CardioBip(TM) for daily monitoring following catheter ablation procedures. The presentation, entitled...

2011-01-10 07:03:00

MORRISVILLE, N.C., Jan. 10, 2011 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias. "nContact's progressive technology and our...

2010-11-10 07:30:00

MORRISVILLE, N.C., Nov. 10, 2010 /PRNewswire/ -- nContact Surgical, Inc. (nContact), a cardiac ablation device manufacturer, announced today that it has closed a $16 million Series D round of equity financing, bringing the company's total financing since inception to $42.4 million. The financing was led by existing investors, Harbert Venture Partners, and included new investors, ZMV Associates. The company expects this financing to support its three ongoing clinical trials, further product...

bcae1f8b3fc6d4a0bf426335afc510501
2010-11-09 08:47:39

By Rachel Champeau, UCLA New study reports on UCLA medical team's experience with new techniques New techniques now being used at UCLA allow doctors to more precisely target certain areas of the heart to stop ventricular arrhythmias "” serious abnormal rhythms in the heart's lower chambers "” in high-risk patients. Generally, arrhythmias can be controlled by medications, and sometimes defibrillators. But a potentially life-threatening, recurrent arrhythmia known as a ventricular...

2010-09-21 06:29:00

DALLAS, September 21, 2010 /PRNewswire/ -- ReportsandReports announces it will carry U.S. Market for Cardiac Rhythm Management, Electrophysiology and Ablation Devices 2010 Research Report in its store. Browse the complete Report on: http://www.reportsandreports.com/reports/34141-us-market-for-cardiac-rhythm-m anagement-electrophysiology-and-.html Search More Then 50000 Market Research Reports at ReportsandReports (http://www.reportsandreports.com/) Browse All IData Research...

2010-05-14 09:11:06

New research presented at National Heart Rhythm Society Sessions shows ablation treatment can eliminate serious risks associated with atrial fibrillation New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia. According to two new studies by the...

2010-05-13 09:36:00

DIAMOND BAR, California, May 13, 2010 /PRNewswire/ -- Biosense Webster, Inc. will underline its leadership position in the electrophysiology market and underscore its commitment to electrophysiologists and their catheter ablation practices at the 2010 Heart Rhythm Meeting. Heart Rhythm is the most important scientific meeting in the field of Electrophysiology and will be held in Denver, CO, USA from May 12th to 15th. This year, Biosense Webster, Inc. will be showcasing its cutting...

2010-05-13 06:30:00

RALEIGH, N.C., May 13 /PRNewswire/ -- nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of Electrophysiologist (EP) catheter and surgical techniques for the treatment of atrial fibrillation (AF) using the investigational Numeris® - AF Guided Coagulation System with VisiTrax®. The three hour procedure is performed in a single setting, generally...

2010-04-21 07:48:00

WALTHAM, Mass., April 21 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, specialty radiofrequency catheters will drive growth in the European catheter market and support the use of catheter ablation as a treatment for atrial fibrillation. According to MRG's new European Markets for Electrophysiology Mapping and Ablation Devices 2010 report, specialty radiofrequency ablation catheter use will grow at a compound...

2010-04-19 07:30:00

MORRISVILLE, N.C., April 19 /PRNewswire/ -- nContact Surgical, Inc ("nContact") today announced it has received the first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to evaluate the safety and efficacy of a combined surgical and catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation (AF). nContact's Numeris®-AF Guided Coagulation System with VisiTrax®...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related